Hrt Financial LP Ab Cellera Biologics Inc. Transaction History

Hrt Financial LP

$20.6 Billion
Q3 2025

A detailed history of Hrt Financial LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Hrt Financial LP holds 436,575 shares of ABCL stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

436,575

Previous 371,013 17.67%

Holding current value

$1.61 Million

Previous $1.27 Million 72.56%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.49 - $5.15 $228,811 - $337,644	65,562 Added 17.67%	436,575 $2.2 Million
Q2 2025 Aug 14, 2025	BUY	$1.93 - $3.8 $343,018 - $675,374	177,730 Added 91.95%	371,013 $1.27 Million
Q1 2025 May 15, 2025	SELL	$2.2 - $3.53 $125,274 - $201,008	-56,943 Reduced 22.76%	193,283 $431,000
Q4 2024 Feb 14, 2025	BUY	$2.48 - $3.15 $298,398 - $379,014	120,322 Added 92.62%	250,226 $733,000
Q3 2024 Nov 12, 2024	BUY	$2.39 - $3.49 $310,470 - $453,364	129,904 New	129,904 $336,000

Q4 2023 Feb 09, 2024	BUY	$3.91 - $5.93 $110,891 - $168,180	28,361 Added 45.6%	90,562 $517,000
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $308,250 - $532,737	-67,011 Reduced 51.86%	62,201 $286,000
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $2.42 Million - $3.24 Million	-427,062 Reduced 76.77%	129,212 $834,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $4.07 Million - $6.22 Million	556,274 New	556,274 $4.19 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $357,888 - $666,349	-62,568 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $466,757 - $884,711	62,568 New	62,568 $610,000
Q2 2021 Aug 16, 2021	SELL	$20.19 - $34.17 $552,519 - $935,096	-27,366 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $637,354 - $1.46 Million	27,366 New	27,366 $929,000

Others Institutions Holding ABCL

# of Institutions

170

Shares Held

110M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account